During the operation process ,we must pay attention points such as
It is enough water in the cooling tank and make it run on the right temperature,lubricant oil capability is good and not exceeded and keep the right pressure in the working range,the frequency is 50HZ and voltage is 400V,the 3 phase current need under the rated range.
Relianle Performance:
1. Impact structure
2. Steady Voltage Regulation Rate:0.5%
3. Transient state voltage regulation rate: -10%---+15%
4. Steady state frequency regulation rate:5%
5. Transient state frequency regulation rate:+10%
6. No-load voltage setting range:(95-105%)
Structure:
1. The generator set features in small volume,light weight and compact structure.
2. The acoustic shield is nice-looking and is convenient to be removed or installed,The set is draughty inside.
3. There are doors on both sides that it makes adding fuel or oil more convenient.
4. The control panel is well designed.The set is easy to control and operates safely its performance is really reliable.
The Main Technical parameter of Silent series Diesel Generator sets:
1. Rated Power(KW/KVA): 300/375
2. Rated Voltage(V) : 400/230 or 220/127
3. Rated Currency(A): 540
4. Rated Frequency(HZ): 50/60
5. Retad Speed(rpm);1500/1600
6. Rated Power Factor: 0.8(lag)
7. Phase Arragement: 3 phase 4 wire
8. Fuel Consumption(m3/kwh): 0.3
Engine Technical:
1.Type:TBD236V8
2. 12h Power/Standby Power(KW): 330/363
3. Starting Mode: DC 24V Electrical Starting
4. Speed Regulation Mode: Mechnical/Electrical
Alternator Parameter:
1. Type: Stamford /Marathon/Xingnuo
2. Rated Power(KW): 300
3. Excitation Mode: AVR Bruchless Excitation With AVR
4. Insulation Class: H (Temperature Rise Limit:125K
5. Protection Class: IP22
6. Control Unit Type: Integral Typ
Natural Gas Generator,Natural Gas Generator for Home,Natural Gas Electric Generator,Portable Natural Gas Generators Weifang Jinma Diesel Engine Co.,Ltd , http://www.goldenhorsepower.com
Biocon is a leading biopharmaceutical company in India. The company said it will invest USD 160 million to build a biotechnology product plant and R&D facility at Bio-XCell, a biotechnology industrial park in Iskandar, Johor, Malaysia, to produce biosimilars and other biopharmaceutical products. The project is expected to start production in 2014. . Iskandar Mizal Mahmood, chairman of Bio-XCell, a biotech industrial park in Malaysia, said that this will be the first high-end biosimilar and biomedical product project in Malaysia. The chairman of Baekang Company, Qi Lan Meizu Da Xiao, said that Baikang chose Malaysia to build a factory because the country’s good infrastructure and government provided favorable tax incentives.
Following the Indian Pakang company, the French bio-chemical company Mai Tuo Polik and the U.S. U.S. Grycos Biotech Corporation also announced their respective project plans at the 2010 Malaysia Biology Conference. The French company stated that under the strong financial support of the Malaysian government, the company will build a bio-process 1,3-propanediol plant at Bio-XCell, a bio-industrial park in Malaysia, with an initial capacity of 8,000 tons/year, and eventually increase the plant's production capacity. To 50,000 tons / year.
U.S. Glicos Biotechnology Corporation and Bio-XCell have signed a definitive agreement to build an industrial biotechnology product factory in this industrial park in 2012, using glycerin and fatty acids produced by the Malaysian tropical oil processing industry as raw materials. Use industrial biotechnology routes to produce a variety of industrial chemicals. The company’s president, Richard Seleto, said that the company’s first goal is to produce isoprene, a key raw material for the tire industry, and that it can also produce propylene glycol, succinic acid, and lactic acid.
Malaysia attracts foreign investment to bio-chemicals
The Malaysian government’s policy of encouraging the development of the biotech industry was positively responded to at the Malaysian Biomeeting 2010 held in Kuala Lumpur last week. Three internationally renowned biotechnology companies - METabolic EXplorer in France, Glycos Biotech in the United States, and Biocon in India have taken hold of the olive branch extended by Malaysia. The country invested in the construction of a biological product factory.